Frontiers in Immunology (May 2024)

Retraction: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

  • Frontiers Editorial Office

DOI
https://doi.org/10.3389/fimmu.2024.1430750
Journal volume & issue
Vol. 15

Abstract

Read online

No abstracts available.